Provigil modafinil: Phase II; marketed to treat excessive daytime sleepiness (EDS) associated with narcolepsy

In a 22-patient U.S. cross-over study comparing Provigil to dextroamphetamine and placebo, an average daily Provigil dose of 200 mg gave a statistically significant ?30 percent reduction in ADHD sympt...